Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,122,337
+$10,612,049 QoQ
Shares Held
452,289
+53.0% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 317 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. VCEL ranks #50 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in VCEL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,122,337 | 452,289 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,510,288 | 295,626 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,093,566 | 280,299 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,655,769 | 243,272 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,276,137 | 76,995 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,355,447 | 97,612 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,144,057 | 75,470 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $972,468 | 23,017 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,833,869 | 39,971 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,538,387 | 29,573 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,647,852 | 102,439 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,006,414 | 179,189 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,983,771 | 79,419 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,139,539 | 72,972 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,761,619 | 66,880 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,537,152 | 109,360 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,091,148 | 83,048 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $483,674 | 12,655 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||